ImmPACT-Bio

ImmPACT-Bio

Verified
Developing novel cell therapies for treating cancer

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$444—666m (Dealroom.co estimates Jan 2022.)
Ness Ziona Center District (HQ)
  • Edit

Recent News about ImmPACT-Bio

Edit